technology Myocardial Infarction Test Kit market analysis report is produced in such a way that it works toward making the reports easier to read, and easier for managers to absorb the information they need to make decisions. The market information of this report is made more accessible to the clients. This industry analysis report contains actionable research and is also educational and entertaining. Continue reading →

HANOVER, Germany--(BUSINESS WIRE)--Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the dosing of the first patient in their multicenter Phase 2 trial assessing efficacy and safety of CDR132L in 280 patients with reduced left ventricular ejection fraction after myocardial infarction (HF-REVERT). Continue reading →

The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer-reviewed. Machine learning identified five subtypes in incident heart failure (HF) with good predictive accuracy for 1-year all-cause mortality. Future trials and clinical practice might be able to use the electronic health record (EHR) and machine learning to identify HF subtypes to aid in management and prognosis. Continue reading →

Heart attacks seem like they happen out of nowhere, but oftentimes there are warning signs that were missed. Nobody thinks they're going to have a heart attack, but every 40 seconds someone in the United States has one. Continue reading →

Angina is a symptom of ischemia to your heart. Ischemia is when proper blood flow is affected. When your heart doesnt get enough blood or oxygen, chest pain can occur Continue reading →

Background Patients with invasive mechanical ventilation may be at high risk of acquiring venous thromboembolism (VTE). Continue reading →